LONDON (AP) — AstraZeneca said Thursday that it intends to seek U.S. approval for its COVID-19 vaccine in the second half of this year, further delaying the long-awaited application.
The FDA has agreed to let adolescents between the ages of 12 and 15 receive the Pfizer COVID-19 vaccine, making it the first available for use in children under 16.
UNMC and Nebraska Medicine plan to enroll up to 50 adolescents ages 12 to 17 in a national clinical trial testing the safety of a vaccine candidate by Novavax. Other trials are expected to enroll even younger participants.
President Joe Biden is setting a new vaccination goal to deliver at least one dose to 70% of adult Americans by July 4. The goal also includes fully vaccinating 160 million adults by then.
America's daily Covid-19 cases and deaths are now about one-fifth of what they were during their winter peaks -- and one expert says the country's improved numbers have a lot to do with the climbing vaccinations.
U.S. regulators say the Baltimore factory contracted to make Johnson & Johnson’s COVID-19 vaccine was dirty, didn’t follow proper manufacturing procedures and had poorly trained staff.
The move comes after six cases in the U.S. of serious blood clots in women who received the vaccine.
Erin McCarthy is part of the Professional Women's Bowling Association.
AstraZeneca is expected to apply in the next few weeks for emergency use authorization for its Covid-19 vaccine in the US, and if and when it does, advisers to the US Food and Drug Administration and the US Centers for Disease Control and Prevention will likely have questions.
The first children have been vaccinated in Moderna's Phase 2/3 pediatric Covid-19 vaccine trial, the company announced Tuesday in a statement.
U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday. Formal authorization is expected soon, with distribution coming within days.
Johnson & Johnson is expected to get an Emergency Use Authorization as early as this weekend for its vaccine candidate, which is likely to mean an extra 15,000 doses for Nebraska in the first week.
Virus update: Johnson & Johnson applied for emergency authorization of its coronavirus vaccine. Plus, the U.S. fell behind in the race to detect dangerous COVID-19 mutations. Here's the latest.
Johnson & Johnson officially asked the Food and Drug Administration for an emergency use authorization of its COVID-19 vaccine Thursday.
Four leading baby food manufacturers sold baby food that contained high levels of toxic heavy metals, a congressional investigation found.
Nineteen retailers were accused of one instance of selling to a minor during the compliance checks, though two were alleged to have made multiple illicit sales.
The Food and Drug Administration says it is "rapidly" working toward issuing an emergency use authorization for the Moderna vaccine -- the second Covid-19 vaccine for the US market -- after the FDA's vaccine advisers voted Thursday to recommend it.
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot from Moderna and the National Institutes of Health to be added to the U.S. vaccination campaign.
The US on Wednesday reported record numbers for Covid-19 cases, hospitalizations and deaths, ahead of a key meeting for what could be the country's second Covid-19 vaccine to get the green light.
The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves. Plus, the pace is intensifying as Washington negotiators try to reach agreement on virus relief.
The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.
A U.S. government advisory panel has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. Here's the latest.
“This treatment isn’t for everybody,” said the chief of Niagara Falls Memorial Medical Center's infectious diseases division.